IBDEI330 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,49206,0)
 ;;=C24.9^^187^2437^7
 ;;^UTILITY(U,$J,358.3,49206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49206,1,3,0)
 ;;=3^Malig Neop Biliary Tract,Unspec
 ;;^UTILITY(U,$J,358.3,49206,1,4,0)
 ;;=4^C24.9
 ;;^UTILITY(U,$J,358.3,49206,2)
 ;;=^5000942
 ;;^UTILITY(U,$J,358.3,49207,0)
 ;;=C90.00^^187^2437^25
 ;;^UTILITY(U,$J,358.3,49207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49207,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,49207,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,49207,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,49208,0)
 ;;=C85.89^^187^2437^29
 ;;^UTILITY(U,$J,358.3,49208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49208,1,3,0)
 ;;=3^NHL NEC,Extranodal & Solid Organ
 ;;^UTILITY(U,$J,358.3,49208,1,4,0)
 ;;=4^C85.89
 ;;^UTILITY(U,$J,358.3,49208,2)
 ;;=^5001730
 ;;^UTILITY(U,$J,358.3,49209,0)
 ;;=C79.51^^187^2437^33
 ;;^UTILITY(U,$J,358.3,49209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49209,1,3,0)
 ;;=3^Secondary Malig Neop Bone
 ;;^UTILITY(U,$J,358.3,49209,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,49209,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,49210,0)
 ;;=C79.52^^187^2437^32
 ;;^UTILITY(U,$J,358.3,49210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49210,1,3,0)
 ;;=3^Secondary Malig Neop  Bone Marrow
 ;;^UTILITY(U,$J,358.3,49210,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,49210,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,49211,0)
 ;;=C92.00^^187^2437^26
 ;;^UTILITY(U,$J,358.3,49211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49211,1,3,0)
 ;;=3^Myelobl Leuk,Acute,No Remiss
 ;;^UTILITY(U,$J,358.3,49211,1,4,0)
 ;;=4^C92.00
 ;;^UTILITY(U,$J,358.3,49211,2)
 ;;=^5001789
 ;;^UTILITY(U,$J,358.3,49212,0)
 ;;=C92.40^^187^2437^31
 ;;^UTILITY(U,$J,358.3,49212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49212,1,3,0)
 ;;=3^Promyelocyt Leuk,Acute,No Remiss
 ;;^UTILITY(U,$J,358.3,49212,1,4,0)
 ;;=4^C92.40
 ;;^UTILITY(U,$J,358.3,49212,2)
 ;;=^5001801
 ;;^UTILITY(U,$J,358.3,49213,0)
 ;;=C92.50^^187^2437^28
 ;;^UTILITY(U,$J,358.3,49213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49213,1,3,0)
 ;;=3^Myelomonocyt Leuk,Acute,No Remiss
 ;;^UTILITY(U,$J,358.3,49213,1,4,0)
 ;;=4^C92.50
 ;;^UTILITY(U,$J,358.3,49213,2)
 ;;=^5001804
 ;;^UTILITY(U,$J,358.3,49214,0)
 ;;=C78.7^^187^2437^37
 ;;^UTILITY(U,$J,358.3,49214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49214,1,3,0)
 ;;=3^Secondary Malig Neop Liver & Intrahep BD
 ;;^UTILITY(U,$J,358.3,49214,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,49214,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,49215,0)
 ;;=C91.10^^187^2437^5
 ;;^UTILITY(U,$J,358.3,49215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49215,1,3,0)
 ;;=3^Lymphocyt Leuk B-Cell,Chr,No Remiss
 ;;^UTILITY(U,$J,358.3,49215,1,4,0)
 ;;=4^C91.10
 ;;^UTILITY(U,$J,358.3,49215,2)
 ;;=^5001765
 ;;^UTILITY(U,$J,358.3,49216,0)
 ;;=D46.9^^187^2437^27
 ;;^UTILITY(U,$J,358.3,49216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49216,1,3,0)
 ;;=3^Myelodysplastic Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,49216,1,4,0)
 ;;=4^D46.9
 ;;^UTILITY(U,$J,358.3,49216,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,49217,0)
 ;;=C79.31^^187^2437^34
 ;;^UTILITY(U,$J,358.3,49217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49217,1,3,0)
 ;;=3^Secondary Malig Neop Brain
 ;;^UTILITY(U,$J,358.3,49217,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,49217,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,49218,0)
 ;;=C79.32^^187^2437^35
